นอร์เวย์ - นอร์เวย์ - Statens legemiddelverk

zambon spa - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

สหภาพยุโรป - นอร์เวย์ - EMA (European Medicines Agency)

zambon spa - safinamidmetansulfonat - parkinsonsykdom - anti-parkinson medisiner - xadago er indisert for behandling av voksne pasienter med idiopatisk parkinsons sykdom (pd) som add-on terapi til en stabil dose levodopa (l-dopa) alene eller i kombinasjon med andre pd legemidler i midt-sent varierende pasienter.

นอร์เวย์ - นอร์เวย์ - Statens legemiddelverk

zambon spa - kolistimetatnatrium - pulver til infusjonsvæske, oppløsning - 1 mill ie

สหภาพยุโรป - นอร์เวย์ - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - narkolepsi - andre nervesystemet narkotika - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

สหภาพยุโรป - นอร์เวย์ - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - sleep apnea, obstructive - andre nervesystemet narkotika - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

สหภาพยุโรป - นอร์เวย์ - EMA (European Medicines Agency)

recordati ireland ltd - silodosin - prostatisk hyperplasi - urologika - behandling av tegn og symptomer på godartet prostatahyperplasi (bph).

นอร์เวย์ - นอร์เวย์ - Statens legemiddelverk

orifarm as - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

นอร์เวย์ - นอร์เวย์ - Statens legemiddelverk

orifarm as - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

นอร์เวย์ - นอร์เวย์ - Statens legemiddelverk

2care4 - kolistimetatnatrium - pulver til inhalasjonsvæske til nebulisator, oppløsning - 1 mill ie

สหภาพยุโรป - นอร์เวย์ - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - andre nervesystemet narkotika - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.